Depot-specific alterations to insulin signaling in mesenteric adipose tissue during intestinal inflammatory response

International Immunopharmacology

Volumn 9, Issue 4, 2009, Pages 396-402

  de Oliveira, Caroline Candida ^a   Acedo, Simone Coghetto ^a   Pedrazzoli Jr , José ^a   Saad, Mario José ^b   Gambero, Alessandra ^a  

^a Universidade Sao Francisco Centro de Ciencias Biologicas e da Saude   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

c Jun N terminal kinase; Colitis; Insulin receptor substrates; Macrophage; TNBS

Indexed keywords

ADIPOCYTOKINE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MYELOPEROXIDASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE RELEASE; HORMONE ACTION; INFLAMMATION; INSULIN RESISTANCE; INTESTINE; LIPID STORAGE; MACROPHAGE; MALE; MESENTERY; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; COLITIS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INTESTINES; MALE; MESENTERY; PEROXIDASE; PHOSPHORYLATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRINITROBENZENESULFONIC ACID; TYROSINE;

EID: 61649111939     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.12.015     Document Type: Article

References (32)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 (2005) 911-919
2. Lago F., Dieguez C., Gómez-Reino J., and Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 3 (2007) 716-724
3. Clement K., and Langin D. Regulation of inflammation-related genes in human adipose tissue. J Intern Med 262 (2007) 422-430
4. Peyrin-Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Gut 56 (2007) 577-583
5. Pond C.M. Paracrine interactions of mammalian adipose tissue. J Exp Zool Part A. Comp Exp Biol 295 (2003) 99-110
6. Schäffler A., Schölmerich J., and Büchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 103-111
7. Paul G., Schäffler A., Neumeier M., Fürst A., Bataillle F., Buechler C., et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 12 (2006) 471-477
8. Klein S. The case of visceral fat: argument for the defense. J Clin Invest 113 (2004) 1530-1532
9. Kawada M., Arihiro A., and Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 13 (2007) 5581-5593
10. Neurath M.F., Fuss I., Kelsall B.L., Stüber E., and Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182 (1995) 1281-1290
11. Ishiguro Y., Sakuraba H., Yamagata K., and Munakata A. The presentation of haptenated proteins and activation of T cells in the mesenteric lymph nodes by dendritic cells in the TNBS colitis rat. Ann N Y Acad Sci 1029 (2004) 346-347
12. Gambero A., Maróstica M., Abdalla Saad M.J., and Pedrazzoli Jr. J. Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflamm Bowel Dis 13 (2007) 1357-1364
13. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
14. Bell C.J., Gall D.G., and Wallace J.L. Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 268 (1995) G622-G630
15. Tilg H., and Moschen A.R. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond) 114 (2008) 275-288
16. Watanabe S., Hojo M., and Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol 42 (2007) 267-274
17. Knight S.C. Specialized perinodal fat fuels and fashions immunity. Immunity 28 (2008) 135-138
18. de Luca C., and Olefsky J.M. Inflammation and insulin resistance. FEBS Lett 582 (2008) 97-105
19. Westcott E., Windsor A., Mattacks C., Pond C., and Knight S. Fatty acid compositions of lipids in mesenteric adipose tissue and lymphoid cells in patients with and without Crohn's disease and their therapeutic implications. Inflamm Bowel Dis 11 (2005) 820-827
20. Sijben J.W., and Calder P.C. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 66 (2007) 237-259
21. Imamura T., Vollenweider P., Egawa K., Clodi M., Ishibashi K., Nakashima N., et al. G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol Cell Biol 19 (1999) 6765-6774
22. Baumann C.A., Ribon V., Kanzaki M., Thurmond D.C., Mora S., Shigematsu S., et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407 (2000) 202-207
23. Chandran M., Phillips S.A., Ciaraldi T., and Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 26 (2003) 2442-2450
24. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005) 939-949
25. Fu Y., Luo N., Klein R.L., and Garvey W.T. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 46 (2005) 1369-1379
26. Thirone A.C., Huang C., and Klip A. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol Metab 17 (2006) 72-78
27. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
28. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., and White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277 (2002) 1531-1537
29. Hirosumi J., Tuncman G., Chang L., Görgün C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
30. Kim K.Y., Kim J.K., Jeon J.H., Yoon S.R., Choi I., and Yang Y. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes. Biochem Biophys Res Commun 327 (2005) 460-467
31. Zeyda M., Farmer D., Todoric J., Aszmann O., Speiser M., Györi G., et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 31 (2007) 1420-1428
32. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281 (2006) 26602-26614